Stay updated on Brentuximab Vedotin ± Nivolumab in CD30+ Lymphoma Clinical Trial

Sign up to get notified when there's something new on the Brentuximab Vedotin ± Nivolumab in CD30+ Lymphoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Brentuximab Vedotin ± Nivolumab in CD30+ Lymphoma Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    The page has been updated to reflect that the study is currently active and not recruiting, with new relevant dates for the study timeline. Additionally, contact information for the principal investigator has been removed.
    Difference
    3%
    Check dated 2025-03-11T00:49:03.000Z thumbnail image
  2. Check
    12 days ago
    No Change Detected
  3. Check
    19 days ago
    Change Detected
    Summary
    The page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.
    Difference
    2%
    Check dated 2025-02-24T20:09:02.000Z thumbnail image
  4. Check
    26 days ago
    No Change Detected
  5. Check
    33 days ago
    Change Detected
    Summary
    The web page now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.
    Difference
    2%
    Check dated 2025-02-10T09:27:15.000Z thumbnail image
  6. Check
    41 days ago
    Change Detected
    Summary
    The website has been updated from version 2.14.1 to 2.14.2.
    Difference
    0.1%
    Check dated 2025-02-03T05:17:56.000Z thumbnail image
  7. Check
    55 days ago
    Change Detected
    Summary
    The website has been updated from version 2.14.0 to 2.14.1.
    Difference
    0.1%
    Check dated 2025-01-19T19:33:40.000Z thumbnail image
  8. Check
    62 days ago
    Change Detected
    Summary
    The website has updated the intervention details and contact information for Principal Investigator Ajay K. Gopal, reflecting a new version (v2.14.0) while removing the previous version (v2.13.3).
    Difference
    2%
    Check dated 2025-01-12T16:48:43.000Z thumbnail image

Stay in the know with updates to Brentuximab Vedotin ± Nivolumab in CD30+ Lymphoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Brentuximab Vedotin ± Nivolumab in CD30+ Lymphoma Clinical Trial page.